Literature DB >> 18241011

Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.

Kevin G Keegan1, Nat T Messer, Shannon K Reed, David A Wilson, Joanne Kramer.   

Abstract

OBJECTIVE: To determine the effectiveness of administering multiple doses of phenylbutazone alone or a combination of phenylbutazone and flunixin meglumine to alleviate lameness in horses. ANIMALS: 29 adult horses with naturally occurring forelimb and hind limb lameness. PROCEDURES: Lameness evaluations were performed by use of kinematic evaluation while horses were trotting on a treadmill. Lameness evaluations were performed before and 12 hours after administration of 2 nonsteroidal anti-inflammatory drug (NSAID) treatment regimens. Phenylbutazone paste was administered at approximately 2.2 mg/kg, PO, every 12 hours for 5 days, or phenylbutazone paste was administered at approximately 2.2 mg/kg, PO, every 12 hours for 5 days in combination with flunixin meglumine administered at 1.1 mg/kg, IV, every 12 hours for 5 days.
RESULTS: Alleviation of lameness was greater after administration of the combination of NSAIDs than after oral administration of phenylbutazone alone. Improvement in horses after a combination of NSAIDs did not completely mask lameness. Five horses did not improve after either NSAID treatment regimen. All posttreatment plasma concentrations of NSAIDs were less than those currently allowed by the United States Equestrian Federation Inc for a single NSAID. One horse administered the combination NSAID regimen died of acute necrotizing colitis during the study. CONCLUSIONS AND CLINICAL RELEVANCE: Administration of a combination of NSAIDs at the dosages and intervals used in the study reported here alleviated the lameness condition more effectively than did oral administration of phenylbutazone alone. This may attract use of combinations of NSAIDs to increase performance despite potential toxic adverse effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241011     DOI: 10.2460/ajvr.69.2.167

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Voltammetric Determination of Flunixin on Molecularly Imprinted Polypyrrole Modified Glassy Carbon Electrode.

Authors:  Abd-Elgawad Radi; Nadia Abd El-Ghany; Tarek Wahdan
Journal:  J Anal Methods Chem       Date:  2016-05-08       Impact factor: 2.193

2.  Palatability and pharmacokinetics of flunixin when administered to sheep through feed.

Authors:  Danila Marini; Joe Pippia; Ian G Colditz; Geoff N Hinch; Carol J Petherick; Caroline Lee
Journal:  PeerJ       Date:  2016-03-14       Impact factor: 2.984

3.  Effect of meloxicam treatment on movement asymmetry in riding horses in training.

Authors:  Emma Persson-Sjodin; Elin Hernlund; Thilo Pfau; Pia Haubro Andersen; Karin Holm Forsström; Marie Rhodin
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

Review 4.  Non-steroidal anti-inflammatory drugs in equine orthopaedics.

Authors:  Carrie C Jacobs; Lauren V Schnabel; C Wayne McIlwraith; Anthony T Blikslager
Journal:  Equine Vet J       Date:  2022-01-25       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.